How to buy Noxopharm shares | A$0.52
Own Noxopharm shares in just a few minutes.
We’re committed to our readers and editorial independence. We don’t compare all products in the market and may receive compensation when we refer you to our partners, but this does not influence our opinions or reviews. Learn more about Finder .
Noxopharm Limited is a biotechnology business based in Australia. Noxopharm shares (NOX) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.52 – an increase of 18.18% over the previous week. Noxopharm has a trailing 12-month revenue of around $8.3 million.
How to buy shares in Noxopharm
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Noxopharm . Find the share by name or ticker symbol: NOX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Noxopharm reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $0.52, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Noxopharm . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
🧪How we chose these brokersFor our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.
How has coronavirus impacted Noxopharm 's share price?
Since the stock market crash in March caused by coronavirus, Noxopharm 's share price has had significant positive movement.
Its last market close was $0.52, which is 41.35% up on its pre-crash value of $0.305 and 447.37% up on the lowest point reached during the March crash when the shares fell as low as $0.095.
If you had bought $1,000 worth of Noxopharm shares at the start of February 2020, those shares would have been worth $522.73 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,363.63.
Noxopharm share priceUse our graph to track the performance of NOX stocks over time.
Noxopharm shares at a glance
|Latest market close||AUDA$0.52|
|52-week range||AUDA$0.095 - AUDA$0.47|
|50-day moving average||AUDA$0.3704|
|200-day moving average||AUDA$0.2721|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||AUDA$-0.092|
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
Important: Share trading carries risk of capital loss.
Compare share trading platforms
Is it a good time to buy Noxopharm stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Noxopharm price performance over time
|1 week (2020-10-15)||23.81%|
|1 month (2020-09-25)||26.83%|
|3 months (2020-07-24)||55.22%|
|6 months (2020-04-24)||188.89%|
|1 year (2019-10-24)||36.84%|
|2 years (2018-10-24)||-21.21%|
|3 years (2017-10-24)||-1.89%|
|5 years (2015-10-21)||N/A|
Is Noxopharm under- or over-valued?
Valuing Noxopharm stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Noxopharm 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Noxopharm 's EBITDA
Noxopharm 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 million.
The EBITDA is a measure of a Noxopharm 's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$8.3 million|
|Gross profit TTM||$8.3 million|
|Return on assets TTM||-41.21%|
|Return on equity TTM||-17.5%|
|Market capitalisation||$110.9 million|
TTM: trailing 12 months
Noxopharm share dividends
We're not expecting Noxopharm to pay a dividend over the next 12 months.
Noxopharm share price volatility
Over the last 12 months, Noxopharm 's shares have ranged in value from as little as $0.095 up to $0.47. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Noxopharm 's is 0.9733. This would suggest that Noxopharm 's shares are less volatile than average (for this exchange).
Noxopharm Limited, a drug development company, focuses on the research and development of drugs to enhance radiotherapy in Australia and internationally. It primarily develops Veyonda, an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also focuses on developing NYX-330, a PCSK9-inhibitor and LDL-cholesterol-lowering drug; NYX-104, a neuroprotectant that protects the brain from further damage after stroke and traumatic brain injury; and NYX-205, an anti-inflammatory drug for the treatment of nerve tissue inflammation. In addition, it develops anti-autoimmune drugs, such as IRAK4 and TPL2 inhibitors; and LuPIN for the combined therapy of Veyonda and 177Lu-PSMA-617. Noxopharm Limited was incorporated in 2015 and is based in Gordon, Australia.
Frequently asked questions
More guides on Finder
Where to buy Xbox One racing wheels online in Australia
A list of stores to buy Xbox One racing wheels online in Australia.
Where to buy Xbox One consoles online in Australia
A list of stores to buy Xbox One consoles online in Australia.
Where to buy Xbox One chargers online in Australia
A list of stores to buy Xbox One chargers online in Australia.
Where to buy Xbox One cables online in Australia
A list of stores to buy Xbox One cables online in Australia.
Where to buy Xbox 360 online in Australia
A list of stores to buy Xbox 360 online in Australia.
Where to buy Xbox 360 remotes online in Australia
A list of stores to buy Xbox 360 remotes online in Australia.
Where to buy Xbox 360 racing wheels online in Australia
A list of stores to buy Xbox 360 racing wheels online in Australia.
Where to buy Xbox 360 headsets online in Australia
A list of stores to buy Xbox 360 headsets online in Australia.
Where to buy Xbox 360 games online in Australia
A list of stores to buy Xbox 360 games online in Australia.
Where to buy Xbox 360 gamepads & standard controllers online in Australia
A list of stores to buy Xbox 360 gamepads & standard controllers online in Australia.
Ask an Expert